<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lo T</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NIH</funding><funding>Harvard Catalyst</funding><funding>U.S. National Institutes of Health</funding><funding>NIH HHS</funding><pagination>e619-e630</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8764221</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>107(2)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To characterize longitudinal changes in blood biomarkers, leukocyte composition, and gene expression following laparoscopic sleeve gastrectomy (LSG).&lt;h4>Background&lt;/h4>LSG is an effective treatment for obesity, leading to sustainable weight loss and improvements in obesity-related comorbidities and inflammatory profiles. However, the effects of LSG on immune function and metabolism remain uncertain.&lt;h4>Methods&lt;/h4>Prospective data were collected from 23 enrolled human subjects from a single institution. Parameters of weight, comorbidities, and trends in blood biomarkers and leukocyte subsets were observed from preoperative baseline to 1 year postsurgery in 3-month follow-up intervals. RNA sequencing was performed on pairs of whole blood samples from the first 6 subjects of the study (baseline and 3 months postsurgery) to identify genome-wide gene expression changes associated with undergoing LSG.&lt;h4>Results&lt;/h4>LSG led to a significant decrease in mean total body weight loss (18.1%) at 3 months and among diabetic subjects a reduction in hemoglobin A1c. Improvements in clinical inflammatory and hormonal biomarkers were demonstrated as early as 3 months after LSG. A reduction in neutrophil-lymphocyte ratio was observed, driven by a reduction in absolute neutrophil counts. Gene set enrichment analyses of differential whole blood gene expression demonstrated that after 3 months LSG induced transcriptomic changes not only in inflammatory cytokine pathways but also in several key metabolic pathways related to energy metabolism.&lt;h4>Conclusions&lt;/h4>LSG induces significant changes in the composition and metabolism of immune cells as early as 3 months postoperatively. Further evaluation is required of bariatric surgery's effects on immunometabolism and the consequences for host defense and metabolic disease.</pubmed_abstract><journal>The Journal of clinical endocrinology and metabolism</journal><pubmed_title>Early Changes in Immune Cell Count, Metabolism, and Function Following Sleeve Gastrectomy: A Prospective Human Study.</pubmed_title><pmcid>PMC8764221</pmcid><funding_grant_id>R01 HL086601</funding_grant_id><funding_grant_id>KL2 TR002542</funding_grant_id><funding_grant_id>UL 1TR002541</funding_grant_id><funding_grant_id>K01 HL127265</funding_grant_id><pubmed_authors>Haridas RS</pubmed_authors><pubmed_authors>Rudge EJM</pubmed_authors><pubmed_authors>Heshmati K</pubmed_authors><pubmed_authors>Croteau-Chonka DC</pubmed_authors><pubmed_authors>Weigl AM</pubmed_authors><pubmed_authors>McNutt SW</pubmed_authors><pubmed_authors>Ituah CO</pubmed_authors><pubmed_authors>Iyoha-Bello OJ</pubmed_authors><pubmed_authors>Tavakkoli A</pubmed_authors><pubmed_authors>Chase RP</pubmed_authors><pubmed_authors>Sathe L</pubmed_authors><pubmed_authors>Lucey EM</pubmed_authors><pubmed_authors>Lo T</pubmed_authors><pubmed_authors>Raby BA</pubmed_authors><pubmed_authors>Farnam L</pubmed_authors><pubmed_authors>Benjamin EJ</pubmed_authors><pubmed_authors>Sheu EG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early Changes in Immune Cell Count, Metabolism, and Function Following Sleeve Gastrectomy: A Prospective Human Study.</name><description>&lt;h4>Objective&lt;/h4>To characterize longitudinal changes in blood biomarkers, leukocyte composition, and gene expression following laparoscopic sleeve gastrectomy (LSG).&lt;h4>Background&lt;/h4>LSG is an effective treatment for obesity, leading to sustainable weight loss and improvements in obesity-related comorbidities and inflammatory profiles. However, the effects of LSG on immune function and metabolism remain uncertain.&lt;h4>Methods&lt;/h4>Prospective data were collected from 23 enrolled human subjects from a single institution. Parameters of weight, comorbidities, and trends in blood biomarkers and leukocyte subsets were observed from preoperative baseline to 1 year postsurgery in 3-month follow-up intervals. RNA sequencing was performed on pairs of whole blood samples from the first 6 subjects of the study (baseline and 3 months postsurgery) to identify genome-wide gene expression changes associated with undergoing LSG.&lt;h4>Results&lt;/h4>LSG led to a significant decrease in mean total body weight loss (18.1%) at 3 months and among diabetic subjects a reduction in hemoglobin A1c. Improvements in clinical inflammatory and hormonal biomarkers were demonstrated as early as 3 months after LSG. A reduction in neutrophil-lymphocyte ratio was observed, driven by a reduction in absolute neutrophil counts. Gene set enrichment analyses of differential whole blood gene expression demonstrated that after 3 months LSG induced transcriptomic changes not only in inflammatory cytokine pathways but also in several key metabolic pathways related to energy metabolism.&lt;h4>Conclusions&lt;/h4>LSG induces significant changes in the composition and metabolism of immune cells as early as 3 months postoperatively. Further evaluation is required of bariatric surgery's effects on immunometabolism and the consequences for host defense and metabolic disease.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2024-11-21T01:37:42.909Z</modification><creation>2024-11-21T01:37:42.909Z</creation></dates><accession>S-EPMC8764221</accession><cross_references><pubmed>34514501</pubmed><doi>10.1210/clinem/dgab673</doi></cross_references></HashMap>